medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2015, Number 07

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (07)

Perinatal complications and serotonin level (5-HT) associated with low birth weight

Hernández-Valencia M, Ruiz-Albarrán M, Vargas-Girón A, Vargas-López C, Saucedo R, Zárate-Treviño A

Language: Spanish
References: 18
Page: 408-413
PDF size: 343.79 Kb.


ABSTRACT

Background: Studies in human and in experimental models suggest that interaction among the adverse prenatal and postnatal environment increases susceptibility for chronic diseases. This environment could induce changes in the metabolism balance.
Objective: To analyze how the low birth weight (LBW) influences on the perinatal complications and serotonin serum concentration associated with the possible changes in the alimentary behavior.
Material and methods: A prospective, longitudinal and descriptive study was made during 6 months of the obstetric events to know the frequency and complications of LBW. To evaluate if these complications could have some relationship with the serotonin concentration we measured through their metabolite 5-hidroxitriptamina (5-HT) and the possible chronic illnesses of the adult life.
Results: From 1,418 obstetric events attended during the study period, 506 patients with viable pregnancies and met the inclusion criteria were included, 26.8% had LBW and the immediate clinical complications were presented in 52.2% of them and serum concentration 5-HT of 362.2+21.8 vs 82.1+13.6 ng/mL.
Conclusion: Low birth weight, besides causing perinatal complications, also conditions permanent changes in the expression of satiety neurotransmitters and some tissues, that alter the regulation mechanisms to maintain the energy balance leading to metabolic stability, which is needed to the proper endocrine functioning in the adult life of these individuals.


REFERENCES

  1. Hernandez-Valencia M, Patti Mary-Elizabeth. Thin Phenotype is protective for impaired glucose tolerance and related to low birth weight. Arch Med Res 2006;37:813- 817.

  2. Lezama HMP, Díaz GJM, Rodríguez ZR. Prevalencia de bajo peso al nacimiento en un Hospital General de segundo nivel. Salud Tab 2001;7:401-403

  3. Hales CN, Barrer DJP, Clark PMS, Cox U, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991;303:1019-1022.

  4. Mi J, Law C, Zhang KL, Osmond C, Stein C, Barker D. Effects of infant birth weight and maternal body mass index in pregnancy on components of the insulin resistance syndrome in China. Ann Intern Med 2000;132:253-260.

  5. Simmons RA, Templeton LJ, Gertz SJ. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 2001; 50: 2279-2286.

  6. Zarate A, Hernández-Valencia M, Tene CE. Impacto clínico de la resistencia a la insulina y la relación con la prevención de diabetes mellitus. Gac Med Mex 1998;134:647-649.

  7. Hochner H, Friedlander Y, Calderon-Margalit R, Meiner V, Sagy Y, Avgil-Tsadok M, Burger A, Savitsky B, Siscovick DS, Manor O. Associations of maternal pregnancy body mass index and gestational weight gain with adult off spring cardiometabolic risk factors. Circulation 2012;125:1381- 1389.

  8. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics 2005;116:473-480.

  9. Jiménez-Chillaron CJ, Hernández-Valencia M, Reamer C, et al. b-Cell secretory dysfunction in the pathogenesis of low birth weight associated diabetes. Diabetes 2005; 54: 702-711

  10. Beltrand J, Nicolescu R, Kaguelidou F, Verkauskiene R, Sibony O, Chevenne D, Claris O, Lévy-Marchal C. Catch-up growth following fetal growth restriction promotes rapid restoration of fat mass but without metabolic consequences at one year of age. PLoS One 2009;4:5343-5346

  11. Bieswal F, Ahn MT, Reusens B, Holvoet P, Raes M, Rees WD, Remacle C. The importance of catch-up growth after early malnutrition for the programming of obesity in male rat. Obesity 2006;14:1330-1343

  12. Artigas F, Sarrias MJ, Martínez E, Gelpi E. Serotonin in body fluids, characterization of human plasmatic and cerebrospinal fluids pools by means of a new HPLC method. Life Sci 1985;37:441-447.

  13. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36:62-67.

  14. Maffeis C, Pinelli L, Brambilla P. Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. Obesity (Silver Spring) 2010;18:1437-1439

  15. Flachaire E, Beney C, Berthier A, Salandre J, Quincy C, Ranaud B. Determination of reference values for serotonin concentration in platelets of healthy newborns, children, adults, and elderly subjects by HPLC with electrochemical detection. Clin Chem 1990;36:2117-2120.

  16. Barber M, Kasturi BS, Austin ME, Patel KP, Mohankumar PS. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res 2003;964:128-135.

  17. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000;279:83-87.

  18. Hall JG. The importance of the fetal origins of adult disease for geneticists. Clin Genet 2007;72:67-73.




2020     |     www.medigraphic.com